Category Stock Exchange

Exicure, Inc. 2025 Financial Results Analysis

[ad_1] XCUR|EPS -$0.79|Rev $0|Net Loss $4.9M Company Overview Exicure, Inc. is a biotechnology company that acquired GPCR USA in January 2025 and is currently exploring strategic alternatives to maximize stockholder value. Key Financial Figures For the year ended December 31,…